Methicillin-Resistant Staphylococcus Aureus: Difference between revisions
No edit summary |
No edit summary |
||
Line 55: | Line 55: | ||
== Associated Co-morbidities == | == Associated Co-morbidities == | ||
Characteristics of Patients at Time of Detection/Identification of MRSA<ref name="Huang">Huang S, Hinrichsen V, Datta R, Spurchise L, Miroshnik I, Nelson K et al. Methicillin-Resistant Staphylococcus aureus Infection and Hospitalization in High-Risk Patients in the Year following Detection. PLoS ONE. 2011;6(9):e24340.</ref><ref name="Datta">Datta R, Huang S. Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases. 2008;47(2):176-181.</ref | Characteristics of Patients at Time of Detection/Identification of MRSA<ref name="Huang">Huang S, Hinrichsen V, Datta R, Spurchise L, Miroshnik I, Nelson K et al. Methicillin-Resistant Staphylococcus aureus Infection and Hospitalization in High-Risk Patients in the Year following Detection. PLoS ONE. 2011;6(9):e24340.</ref><ref name="Datta">Datta R, Huang S. Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases. 2008;47(2):176-181.</ref> | ||
*Heart Disease | |||
*Asthma | |||
*Diabetes Mellitus | |||
*End-Stage Renal Disease | |||
*End-Stage Liver Disease | |||
*Immunocompromised, Non-cancer<br> | |||
*Solid-Organ Cancer | *Solid-Organ Cancer | ||
*Hematologic Malignancy | *Hematologic Malignancy<br> | ||
== Medications == | == Medications == |
Revision as of 03:37, 8 April 2016
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Top Contributors - Kory Reynolds, Sarah Tassinari, Lucinda hampton, Elaine Lonnemann, 127.0.0.1, Kim Jackson, Evan Thomas, WikiSysop and Nupur Smit Shah
Definition/Description[edit | edit source]
add text here
Prevalence[edit | edit source]
According to the 2012 US Census Data[1]
- Non-Dialysis Patients: 65,296
- Dialysis Patients: 14,041
- TOTAL 75,309
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities[edit | edit source]
Characteristics of Patients at Time of Detection/Identification of MRSA[2][3]
- Heart Disease
- Asthma
- Diabetes Mellitus
- End-Stage Renal Disease
- End-Stage Liver Disease
- Immunocompromised, Non-cancer
- Solid-Organ Cancer
- Hematologic Malignancy
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Recent Related Research (from Pubmed)[edit | edit source]
Resources
[edit | edit source]
add appropriate resources here
References[edit | edit source]
see adding references tutorial.
- ↑ MRSA Tracking | MRSA | CDC [Internet]. Cdc.gov. 2016 [cited 7 April 2016]. Available from: http://www.cdc.gov/mrsa/tracking/index.html
- ↑ Huang S, Hinrichsen V, Datta R, Spurchise L, Miroshnik I, Nelson K et al. Methicillin-Resistant Staphylococcus aureus Infection and Hospitalization in High-Risk Patients in the Year following Detection. PLoS ONE. 2011;6(9):e24340.
- ↑ Datta R, Huang S. Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases. 2008;47(2):176-181.